Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.

Onieva JL, Pérez-Ruiz E, Figueroa-Ortiz LC, Jurado JM, Martínez B, Carlos Benítez J, Rueda-Domínguez A, Barragán I

Open source

DOI
10.1136/jitc-2025-013592
Published
2026 Jan 16
Container
Journal for immunotherapy of cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-013592,
  title = {Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.},
  author = {Onieva JL and Pérez-Ruiz E and Figueroa-Ortiz LC and Jurado JM and Martínez B and Carlos Benítez J and Rueda-Domínguez A and Barragán I},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2025-013592},
  url = {https://doi.org/10.1136/jitc-2025-013592}
}

RIS

TY  - JOUR
TI  - Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.
AU  - Onieva JL
AU  - Pérez-Ruiz E
AU  - Figueroa-Ortiz LC
AU  - Jurado JM
AU  - Martínez B
AU  - Carlos Benítez J
AU  - Rueda-Domínguez A
AU  - Barragán I
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2025-013592
UR  - https://doi.org/10.1136/jitc-2025-013592
ER  - 

APA

JL, O., E, P., LC, F., JM, J., B, M., J, C. B., A, R., & I, B. (2026). Integrative multiomic profiling of cfDNA methylation and EV-miRNAs identifies immunotherapy-outcome molecular subtypes in NSCLC.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2025-013592

Source records